Literature DB >> 19264908

Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

Tamami Tanaka1, Kent Doi, Rui Maeda-Mamiya, Kousuke Negishi, Didier Portilla, Takeshi Sugaya, Toshiro Fujita, Eisei Noiri.   

Abstract

This study aimed to elucidate the role of L-type fatty acid-binding protein (L-FABP) in renal tubulointerstitial injury using a mouse adenine-induced renal injury model. C57BL/6 mice fed excess dietary adenine for 6 weeks showed a gradual increase in levels of blood urea nitrogen (BUN). They also showed severe tubulointerstitial pathological findings, such as fibrosis and macrophage infiltration without glomerular damage, which were attenuated by treatment with either allopurinol or Y-700, a new xanthine dehydroxygenase inhibitor. Because renal expression of L-FABP is defective in C57BL/6 mice, human L-FABP transgenic mice were fed an adenine-containing diet. Transgenic mice showed lower BUN levels and lower levels of pathological injury compared with wild-type mice. On the other hand, urinary levels and renal expression of L-FABP in the adenine group was significantly increased and attenuated by treatment with either allopurinol or Y-700. Urinary L-FABP was positively correlated with BUN levels and pathological damages in the tubulointerstitium. No increases in urinary protein, albumin, or N-acetyl-beta-D-glucosaminidase levels were found for 6 weeks in any group. In conclusion, we demonstrated that urinary L-FABP levels can be used to monitor both dynamics and drug responses in a mouse adenine-induced tubulointerstitial injury model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264908      PMCID: PMC2671353          DOI: 10.2353/ajpath.2009.080511

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Clinical practice. Gout.

Authors:  Robert A Terkeltaub
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

3.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 4.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

Authors:  R E Gilbert; M E Cooper
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

5.  Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland.

Authors:  V Edvardsson; R Palsson; I Olafsson; G Hjaltadottir; T Laxdal
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

Review 6.  New insights into the structure and function of fatty acid-binding proteins.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

7.  Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.

Authors:  Ken Ataka; Hiroki Maruyama; Tomohiro Neichi; Jun-ichi Miyazaki; Fumitake Gejyo
Journal:  Am J Nephrol       Date:  2003-08-12       Impact factor: 3.754

8.  A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.

Authors:  K Negishi; E Noiri; T Sugaya; S Li; J Megyesi; K Nagothu; D Portilla
Journal:  Kidney Int       Date:  2007-05-09       Impact factor: 10.612

9.  Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

Authors:  K Negishi; E Noiri; R Maeda; D Portilla; T Sugaya; T Fujita
Journal:  Kidney Int       Date:  2008-03-26       Impact factor: 10.612

10.  Renal L-type fatty acid--binding protein in acute ischemic injury.

Authors:  Tokunori Yamamoto; Eisei Noiri; Yoshinari Ono; Kent Doi; Kousuke Negishi; Atsuko Kamijo; Kenjiro Kimura; Toshiro Fujita; Tsuneo Kinukawa; Hideki Taniguchi; Kazuo Nakamura; Momokazu Goto; Naoshi Shinozaki; Shinichi Ohshima; Takeshi Sugaya
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

View more
  26 in total

1.  Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.

Authors:  Mark R Hanudel; Kristine Chua; Maxime Rappaport; Victoria Gabayan; Erika Valore; David Goltzman; Tomas Ganz; Elizabeta Nemeth; Isidro B Salusky
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-12

2.  Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.

Authors:  Li-Juan Duan; Kotaro Takeda; Guo-Hua Fong
Journal:  Am J Pathol       Date:  2014-02-06       Impact factor: 4.307

3.  Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.

Authors:  Hermine I Brunner; Michael R Bennett; Gaurav Gulati; Khalid Abulaban; Marisa S Klein-Gitelman; Stacy P Ardoin; Lori B Tucker; Kelly A Rouster-Stevens; David Witte; Jun Ying; Prasad Devarajan
Journal:  J Rheumatol       Date:  2017-06-15       Impact factor: 4.666

Review 4.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

5.  Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.

Authors:  Eikan Mishima; Shinji Fukuda; Hisato Shima; Akiyoshi Hirayama; Yasutoshi Akiyama; Yoichi Takeuchi; Noriko N Fukuda; Takehiro Suzuki; Chitose Suzuki; Akinori Yuri; Koichi Kikuchi; Yoshihisa Tomioka; Sadayoshi Ito; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2014-12-18       Impact factor: 10.121

6.  Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.

Authors:  Jing Cao; Wei Wang; Yong Li; Jieyun Xia; Yingxian Peng; Yaqian Zhang; Anzhou Xia
Journal:  Int Urol Nephrol       Date:  2016-02-10       Impact factor: 2.370

7.  Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?

Authors:  Meryem Benzer; Sebnem Tekin Neijmann; Nazlı Dilay Gültekin; Aslı Uluturk Tekin
Journal:  Int Urol Nephrol       Date:  2016-08-22       Impact factor: 2.370

8.  Pharmacologic Blockade of αvβ1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo.

Authors:  Yongen Chang; Wei Ling Lau; Hyunil Jo; Kazuyuki Tsujino; Leslie Gewin; Nilgun Isik Reed; Amha Atakilit; Ane Claudia Fernandes Nunes; William F DeGrado; Dean Sheppard
Journal:  J Am Soc Nephrol       Date:  2017-02-20       Impact factor: 10.121

9.  Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Authors:  Paweena Susantitaphong; Monchai Siribamrungwong; Kent Doi; Eisei Noiri; Norma Terrin; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-12-08       Impact factor: 8.860

10.  Measurement of urinary biomarkers in a case of tubulointerstitial nephritis and uveitis syndrome during glucocorticoid treatment.

Authors:  Masafumi Sugiyama
Journal:  CEN Case Rep       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.